Dr. Reddys Laboratories trades with traction on the bourses

21 Oct 2016 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 3114.00, up by 38.35 points or 1.25% from its previous closing of Rs. 3075.65 on the BSE.

The scrip opened at Rs. 3090.00 and has touched a high and low of Rs. 3123.00 and Rs. 3087.00 respectively. So far 12286 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4375.30 on 04-Nov-2015 and a 52 week low of Rs. 2750.00 on 21-Jan-2016.

Last one week high and low of the scrip stood at Rs. 3123.00 and Rs. 3011.15 respectively. The current market cap of the company is Rs. 53235.88 crore.

The promoters holding in the company stood at 26.68%, while institutions and non-institutions held 43.64% and 12.69% respectively.

Dr. Reddy’s Laboratories has launched Aripiprazole tablets, USP, in 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, a therapeutic equivalent generic version of Abilify (aripiprazole) tablets in the United States market approved by the US Food & Drug Administration (USFDA). Dr. Reddy’s Aripiprazole tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg are available in bottle count sizes of 30.

The Abilify brand and generic tablets had US sales of approximately $3.1 billion MAT for the most recent twelve months ending in August 2016, according to IMS Health. Abilify is a registered trademark of Otsuka Pharmaceutical Company.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1279.65 6.70 (0.53%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×